FDA Approves Inlyta To Treat Patients With a Type of Advanced Kidney Cancer
Sacramento Bee
Recently approved drugs for the treatment of kidney cancer include sorafenib (2005), sunitinib (2006), temsirolimus (2007), everolimus (2009), bevacizumab (2009) and pazopanib (2009). The safety and effectiveness of Inlyta were evaluated in a single ...
FDA Approves Axitinib for Advanced Kidney CancerThe Oncology Report
FDA OKs Axitinib for Kidney CancerMedPage Today

all 198 news articles »